VANTIVA SA (VANTI.PA)

FR0013505062 - Common Stock

0.108  +0 (+1.31%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to VANTI. VANTI was compared to 23 industry peers in the Communications Equipment industry. VANTI may be in some trouble as it scores bad on both profitability and health. VANTI does not seem to be growing, but still is valued expensively.



3

1. Profitability

1.1 Basic Checks

VANTI had negative earnings in the past year.
VANTI had a positive operating cash flow in the past year.
VANTI had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: VANTI reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of -12.14%, VANTI is doing worse than 65.22% of the companies in the same industry.
With a decent Return On Invested Capital value of 2.66%, VANTI is doing good in the industry, outperforming 69.57% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for VANTI is below the industry average of 5.75%.
The last Return On Invested Capital (2.66%) for VANTI is above the 3 year average (1.91%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -12.14%
ROE N/A
ROIC 2.66%
ROA(3y)-5.11%
ROA(5y)-5.88%
ROE(3y)-1602.43%
ROE(5y)-1114.33%
ROIC(3y)1.91%
ROIC(5y)N/A

1.3 Margins

With a Operating Margin value of 1.03%, VANTI perfoms like the industry average, outperforming 52.17% of the companies in the same industry.
In the last couple of years the Operating Margin of VANTI has grown nicely.
With a Gross Margin value of 14.06%, VANTI is not doing good in the industry: 91.30% of the companies in the same industry are doing better.
VANTI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.03%
PM (TTM) N/A
GM 14.06%
OM growth 3YN/A
OM growth 5Y19.94%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.96%
GM growth 5Y1.75%

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VANTI is destroying value.
The number of shares outstanding for VANTI remains at a similar level compared to 1 year ago.
VANTI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, VANTI has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.36, we must say that VANTI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of VANTI (0.36) is worse than 73.91% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.36
ROIC/WACC0.41
WACC6.49%

2.3 Liquidity

A Current Ratio of 0.77 indicates that VANTI may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.77, VANTI is doing worse than 95.65% of the companies in the same industry.
VANTI has a Quick Ratio of 0.77. This is a bad value and indicates that VANTI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of VANTI (0.55) is worse than 91.30% of its industry peers.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.55

2

3. Growth

3.1 Past

VANTI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -396.22%.
The Revenue has decreased by -7.77% in the past year.
Measured over the past years, VANTI shows a very negative growth in Revenue. The Revenue has been decreasing by -12.25% on average per year.
EPS 1Y (TTM)-396.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.08%
Revenue 1Y (TTM)-7.77%
Revenue growth 3Y-11.62%
Revenue growth 5Y-12.25%
Sales Q2Q%-3.28%

3.2 Future

Based on estimates for the next years, VANTI will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.37% on average per year.
VANTI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.36% yearly.
EPS Next Y-113.05%
EPS Next 2Y-21.14%
EPS Next 3Y16.37%
EPS Next 5YN/A
Revenue Next Year-4.74%
Revenue Next 2Y0.72%
Revenue Next 3Y1.36%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VANTI. In the last year negative earnings were reported.
Also next year VANTI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

VANTI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VANTI is cheaper than 95.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.35

4.3 Compensation for Growth

VANTI's earnings are expected to grow with 16.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-21.14%
EPS Next 3Y16.37%

0

5. Dividend

5.1 Amount

No dividends for VANTI!.
Industry RankSector Rank
Dividend Yield N/A

VANTIVA SA

EPA:VANTI (9/13/2024, 7:00:00 PM)

0.108

+0 (+1.31%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap52.93M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.14%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 1.03%
PM (TTM) N/A
GM 14.06%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.77
Quick Ratio 0.55
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-396.22%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-113.05%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-7.77%
Revenue growth 3Y-11.62%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y